Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Income Statement
Earnings Waterfall
Brainstorm Cell Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-21.4m
USD
|
Operating Income
|
-21.4m
USD
|
Other Expenses
|
4.2m
USD
|
Net Income
|
-17.2m
USD
|
Income Statement
Brainstorm Cell Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(9)
|
(10)
|
(10)
|
(9)
|
(8)
|
(7)
|
(6)
|
(5)
|
(5)
|
(5)
|
(6)
|
(5)
|
(6)
|
(8)
|
(8)
|
(14)
|
(17)
|
(18)
|
(21)
|
(23)
|
(26)
|
(29)
|
(28)
|
(32)
|
(30)
|
(29)
|
(30)
|
(25)
|
(23)
|
(25)
|
(26)
|
(25)
|
(25)
|
(22)
|
(22)
|
(21)
|
|
Selling, General & Administrative |
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
(10)
|
(9)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(10)
|
(10)
|
(10)
|
(11)
|
|
Research & Development |
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(5)
|
(5)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(1)
|
(1)
|
(2)
|
(3)
|
(8)
|
(11)
|
(13)
|
(15)
|
(17)
|
(20)
|
(22)
|
(20)
|
(22)
|
(21)
|
(19)
|
(20)
|
(15)
|
(14)
|
(15)
|
(15)
|
(14)
|
(14)
|
(12)
|
(11)
|
(11)
|
|
Operating Income |
(5)
N/A
|
(5)
+1%
|
(5)
+4%
|
(6)
-28%
|
(7)
-21%
|
(9)
-16%
|
(10)
-12%
|
(10)
-1%
|
(9)
+13%
|
(8)
+5%
|
(7)
+17%
|
(6)
+14%
|
(5)
+13%
|
(5)
+1%
|
(5)
-2%
|
(6)
-15%
|
(5)
+15%
|
(6)
-11%
|
(8)
-36%
|
(8)
-11%
|
(14)
-68%
|
(17)
-19%
|
(18)
-11%
|
(21)
-13%
|
(23)
-11%
|
(26)
-15%
|
(29)
-10%
|
(28)
+4%
|
(32)
-14%
|
(30)
+4%
|
(29)
+4%
|
(30)
-3%
|
(25)
+18%
|
(23)
+6%
|
(25)
-6%
|
(26)
-6%
|
(25)
+5%
|
(25)
+1%
|
(22)
+9%
|
(22)
+4%
|
(21)
+1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
|
Total Other Income |
0
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
1
|
1
|
1
|
1
|
0
|
(0)
|
(0)
|
|
Pre-Tax Income |
(5)
N/A
|
(6)
-21%
|
(6)
-8%
|
(8)
-21%
|
(9)
-19%
|
(9)
-1%
|
(10)
-3%
|
(10)
-2%
|
(8)
+14%
|
(8)
+5%
|
(7)
+16%
|
(6)
+15%
|
(5)
+13%
|
(5)
N/A
|
(5)
-2%
|
(6)
-16%
|
(5)
+15%
|
(5)
-10%
|
(8)
-38%
|
(8)
-10%
|
(14)
-68%
|
(17)
-20%
|
(18)
-11%
|
(21)
-13%
|
(23)
-11%
|
(26)
-13%
|
(29)
-9%
|
(28)
+4%
|
(32)
-15%
|
(30)
+5%
|
(29)
+4%
|
(30)
-3%
|
(24)
+19%
|
(23)
+5%
|
(24)
-3%
|
(25)
-6%
|
(24)
+5%
|
(24)
+1%
|
(22)
+7%
|
(17)
+25%
|
(17)
-3%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(5)
|
(6)
|
(6)
|
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(8)
|
(8)
|
(7)
|
(6)
|
(5)
|
(5)
|
(5)
|
(6)
|
(5)
|
(5)
|
(8)
|
(8)
|
(14)
|
(17)
|
(18)
|
(21)
|
(23)
|
(26)
|
(29)
|
(28)
|
(32)
|
(30)
|
(29)
|
(30)
|
(24)
|
(23)
|
(24)
|
(25)
|
(24)
|
(24)
|
(22)
|
(17)
|
(17)
|
|
Net Income (Common) |
(5)
N/A
|
(6)
-21%
|
(6)
-8%
|
(8)
-21%
|
(9)
-20%
|
(9)
-1%
|
(10)
-3%
|
(10)
-2%
|
(8)
+14%
|
(8)
+5%
|
(7)
+16%
|
(6)
+15%
|
(5)
+13%
|
(5)
N/A
|
(5)
-2%
|
(6)
-16%
|
(5)
+15%
|
(5)
-10%
|
(8)
-38%
|
(8)
-10%
|
(14)
-68%
|
(17)
-20%
|
(18)
-11%
|
(21)
-13%
|
(23)
-11%
|
(26)
-13%
|
(29)
-9%
|
(28)
+4%
|
(32)
-15%
|
(30)
+5%
|
(29)
+4%
|
(30)
-3%
|
(24)
+19%
|
(23)
+5%
|
(24)
-3%
|
(25)
-6%
|
(24)
+5%
|
(24)
+1%
|
(22)
+7%
|
(17)
+25%
|
(17)
-3%
|
|
EPS (Diluted) |
-0.39
N/A
|
-0.5
-28%
|
-0.51
-2%
|
-0.5
+2%
|
-0.68
-36%
|
-0.51
+25%
|
-0.52
-2%
|
-0.53
-2%
|
-0.46
+13%
|
-0.43
+7%
|
-0.36
+16%
|
-0.31
+14%
|
-0.27
+13%
|
-0.27
N/A
|
-0.28
-4%
|
-0.32
-14%
|
-0.26
+19%
|
-0.3
-15%
|
-0.4
-33%
|
-0.42
-5%
|
-0.7
-67%
|
-0.81
-16%
|
-0.85
-5%
|
-0.94
-11%
|
-1.06
-13%
|
-0.92
+13%
|
-0.98
-7%
|
-0.88
+10%
|
-1.07
-22%
|
-0.84
+21%
|
-0.8
+5%
|
-0.82
-2%
|
-0.68
+17%
|
-0.64
+6%
|
-0.66
-3%
|
-0.7
-6%
|
-0.66
+6%
|
-0.66
N/A
|
-0.56
+15%
|
-0.37
+34%
|
-0.4
-8%
|